Immunomodulatory roles of topical dinitrochlorobenzene treatment in Herpes simplex virus infection

International Immunopharmacology

Volumn 9, Issue 7-8, 2009, Pages 984-989

  Yamaji, Masahiro ^a,b   Shudo, Jutaro ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b NEC Corporation of America   (United States)

Author keywords

Allergic contact dermatitis; Anti virus; Contact sensitizers; Cytokine

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; CYTOKINE; GAMMA INTERFERON; MESSENGER RNA; T LYMPHOCYTE ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG INDICATION; HERPES SIMPLEX; HERPES VIRUS INFECTION; IMMUNOMODULATION; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION; T LYMPHOCYTE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIGEN PRESENTATION; CELL PROLIFERATION; CERCOPITHECUS AETHIOPS; DERMATITIS, CONTACT; DINITROCHLOROBENZENE; GELS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; IMMUNIZATION; INTERFERON-GAMMA; LYMPH NODES; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; SKIN; T-LYMPHOCYTES; VIRULENCE;

EID: 65849391592     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2009.04.004     Document Type: Article

References (36)

1. Grable, and Schwarz T. Immunoreguratory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 19 (1998) 37-43
2. Rycroft R.J.G., Menne T., and Frosch P.J. Textbook of contact dermatitis (1995), Springer, Berlin
3. Cella M., Sallusto F., and Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9 (1977) 10-16
4. Nakano Y. Antigen-presenting cell function of epidermal cells activated by hapten application. Br J Dermatol 138 (1998) 786-794
5. Saint-Mezard P., Rosieres A., Krasteva M., Berard F., Dubois B., Kaiserlian D., et al. Allergic contact dermatitis. Eur J Dermatol 14 (2004) 284-295
6. Girolomoni G., Gisondi P., Ottaviani C., and Cavani A. Immunoregulation of allergic contact dermatitis. J Dermatol 31 (2004) 264-270
7. Holzer A.M., Kaplan L.L., and Levis W.R. Haptens as drugs: contact allergens are powerful topical immunomodulators. J Drugs Dermatol 5 (2006) 410-416
8. Weisburger E.K., Russfield A.B., Homburger F., et al. Testing of 21 environmental aromatic amines or derivatives for long-term toxicity or carcinogenicity. J Environ Pathol Toxicol 2 (1978) 325-356
9. Matsumoto M., Aiso S., Senoh H., Yamazaki K., Arito H., Nagano K., et al. Carcinogenecity and chronic toxicity of para-chloronitrobenzene in rats and mice by two-year feeding. J Environ Pathol Toxicol Oncol 25 3 (2006) 571-584
10. Matsumoto M., Umeda Y., Senoh H., Suzuki M., Kano H., Katagiri T., et al. Two-year feed study of carcinogenicity and chronic of ortho-chloronitrobenzene in rats and mice. J Environ Pathol Toxicol Oncol 31 3 (2006 Aug) 247-264
11. Herbst-Kralovetz M., and Pyles R. Toll-like receptors, innate immunity and HSV pathogenesis. Herpes 13 (2006) 37-41
12. Wakimoto H., Johnson P.R., Knipe D.M., and Chiocca E.A. Effects of innate immunity on herpes simplex virus and its ability to kill tumor cells. Gene Ther 10 (2003) 983-990
13. Gresser I., Tovey M.G., Maury C., and Bandu M.T. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J Exp Med 144 (1976) 1316-1323
14. Vollstedt S., Arnold S., Schwerdel C., Franchini M., Alber G., Di Santo J.P., et al. Interplay between alpha/beta and gamma interferons with B, T, and natural killer cells in the defense against herpes simplex virus type 1. J Virol 78 (2004) 3846-3850
15. Hochrein H., Schlatter B., O'Keeffe M., Wagner C., Schmitz F., Schiemann M., et al. Herpes simplex virus type-1 induces IFN-α production via Toll-like receptor 9-dependent and -independent pathways. Proc Natl Acad Sci USA 101 (2004) 11416-11421
16. Krug A., Luker G.D., Barchet W., Leib D.A., Akira S., and Colonna M. Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. Blood 103 (2004) 1433-1437
17. Kassim S.H., Rajasagi N.K., Zhao X., Chervenak R., and Jennings S.R. In vivo ablation of CD11c-positive dendritic cells increases susceptibility to herpes simplex virus type 1 infection and diminishes NK and T-cell responses. J Virol 80 (2006) 3985-3993
18. Pollara G., Speidel K., Samady L., Rajpopat M., McGrath Y., Ledermann J., et al. Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunity. J Infect Dis 187 (2003) 165-178
19. + dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1. J Immunol 170 (2003) 4437-4440
20. Ellermann-Eriksen S. Macrophages and cytokines in the early defence against herpes simplex virus. Virol J 2 (2005) 59
21. Malmgaard L., Melchjorsen J., Bowie A.G., Mogensen S.C., and Paludan S.R. Viral activation of macrophages through TLR-dependent and -independent pathways. J Immunol 173 (2004) 6890-6898
22. Ghiasi H., Osorio Y., Nesburn A.B., and Wechsler S.L. Enhanced clearance of herpes simplex virus type 1 and reduced herpetic eye disease in STAT6 knockout mice is associated with increased IL-2. Virology 302 (2002) 286-293
23. Simmons A., and Tscharke D.C. Anti-CD8 impairs clearance of herpes simplex virus from the nervous system: implications for the fate of virally infected neurons. J Exp Med 175 (1992) 1337-1344
24. + T cells into the nervous system following ocular herpes simplex virus-1 infection. J Immunol 174 (2005) 2919-2925
25. Lewis H.M. Topical immunotherapy of refractory warts. Cutis 12 (1973) 863-867
26. Johansson E., and Forsatrom L. Dinitrochlorobenzene (DNCB) treatment of viral warts. Acta Derm Venereol [Stockh] 64 (1984) 529-533
27. Stricker RB Elswood B.F., Goldberg B., et al. Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene. J Am Acad Dermatol 31 (1994) 462-466
28. Trub A., Margulis S.B., and Stricker R.B. Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil. Dermatology 197 (1997) 369-373
29. Oracion R., Adams M., Sharp K., et al. DNCB treatment of HIV-infected patients leads to beneficial immunologic outcomes, reduced viral loads, and improved measures of quality of life. J Invest Dermatol 110 (1998) 476
30. McLelland J., Shuster S., and Matthews J.N.S. "Irritants" increase the response to an allergen in an allergic contact dermatitis. Arch Dermatol 127 (1991) 1016-1019
31. Enk A.H., and Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89 (1992) 1398-1402
32. Enk A.H., An geloni V.L., Udey M.C., and Katz S.I. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin. J Immunol 150 (1993) 3698-3704
33. Kondo S., Pastore S., Shivji G.M., McKenzie R.C., and Sauder D.N. Characterization of epidermal cytokine profiles in sensitization and elicitation phases of allergic contact dermatitis as well as irritant contact dermatitis in mouse skin. Lymphokine Cytokine Res 13 (1994) 367-375
34. Belardelli F., and Ferrantini M. Cytokines as a link between innate and adaptive antitumor immunity. Trends Immunol 23 (2002) 201-208
35. Okazaki F., Kanzaki H., Fujii K., Arata J., Akiba H., Tsujii K., et al. Initial recruitment of interferon-gamma-producing CD8+ effector cells, followed by infiltration of CD4+ cells in 2,4,6-trinitro-1-chlorobenzene (TNCB)-induced murine contact hypersensitivity reactions. J Dermatol 29 (2002) 699-708
36. Wack C., Kirst A., Becker J.C., Lutz W.K., Brocker E.B., and Fischer W.H. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response. Cancer Immunol Immunother 51 (2002) 431-439